scholarly journals Secukinumab for Long-Term Treatment of Psoriatic Arthritis: A Two-Year Followup From a Phase III, Randomized, Double-Blind Placebo-Controlled Study

2017 ◽  
Vol 69 (3) ◽  
pp. 347-355 ◽  
Author(s):  
Arthur Kavanaugh ◽  
Philip J. Mease ◽  
Andreas M. Reimold ◽  
Hasan Tahir ◽  
Jürgen Rech ◽  
...  
Keyword(s):  
Psoriatic Arthritis ◽  
Term Treatment ◽  
Phase Iii ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Long Term Treatment

Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study

2004 ◽  
Vol 82 (1) ◽  
pp. 145-148 ◽  
Author(s):  
Vittorio Unfer ◽  
Maria Luisa Casini ◽  
Loredana Costabile ◽  
Marcella Mignosa ◽  
Sandro Gerli ◽  
...  
Keyword(s):  
Term Treatment ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Long Term Treatment

Long-term treatment of ulcerative colitis with ciprofloxacin: A prospective, double-blind, placebo-controlled study

1998 ◽  
Vol 115 (5) ◽  
pp. 1072-1078 ◽  
Author(s):  
U TURUNEN ◽  
M FARKKILA ◽  
K HAKALA ◽  
K SEPPALA ◽  
A SIVONEN ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Term Treatment ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Long Term Treatment

Effect of Anticholinergics on Tardive Dyskinesia

1984 ◽  
Vol 145 (3) ◽  
pp. 304-310 ◽  
Author(s):  
W. Greil ◽  
H. Haag ◽  
G. Rossnagl ◽  
E. Rüther
Keyword(s):  
Tardive Dyskinesia ◽  
Rating Scales ◽  
Term Treatment ◽  
Controlled Study ◽  
Anticholinergic Medication ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Long Term Treatment ◽  
Schizophrenic Patients

SummaryIn a double-blind, placebo-controlled study, ten chronic schizophrenic patients with pronounced symptoms of tardive dyskinesia (TD) were withdrawn from anticholinergic medication. All patients had previously been under long-term treatment with neuroleptics and anticholinergics for at least two years. The rating-scales used were the AIMS, our own TD Scale, and the Simpson-Angus scale for extra-pyramidal side-effects. The severity of TD decreased significantly in nine patients within two weeks; this improvement, most pronounced in the oral region (P <.001), persisted during a six-week placebo period. There was a slight increase in parkinsonian symptoms (P <.05), which was not a prerequisite for improvement in TD. Hence, discontinuation of anticholinergic medication is a possible therapeutic approach in patients with TD.

scholarly journals Effects of long-term treatment with oxytocin in chronic constipation; a double blind, placebo-controlled pilot trial

2005 ◽  
Vol 17 (5) ◽  
pp. 697-704 ◽  
Author(s):  
b. ohlsson ◽  
m. truedsson ◽  
m. bengtsson ◽  
r. torstenson ◽  
k. sjolund ◽  
...  
Keyword(s):  
Chronic Constipation ◽  
Pilot Trial ◽  
Term Treatment ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Long Term Treatment

Efficacy of Milnacipran Following Long-Term Treatment of Fibromyalgia: Results from a Randomized, Double-Blind, Placebo-Controlled Discontinuation Study (P07.270)

Neurology ◽  
2012 ◽  
Vol 78 (Meeting Abstracts 1) ◽  
pp. P07.270-P07.270
Author(s):  
D. Clauw ◽  
P. Mease ◽  
Y. Ma ◽  
A. Baldecchi ◽  
R. Palmer ◽  
...  
Keyword(s):  
Term Treatment ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Long Term Treatment
Sign in / Sign up

Export Citation Format

Share Document